Subodh Kumar, P. Sarma, R. Singh, D. Reddy, Sukhjinder Singh, Ashutosh Singh, B. Medhi
{"title":"纳米技术在癌症中的应用:综述基于纳米医学的联合治疗中患者筛查的重要性","authors":"Subodh Kumar, P. Sarma, R. Singh, D. Reddy, Sukhjinder Singh, Ashutosh Singh, B. Medhi","doi":"10.32474/ANOAJ.2018.01.000112","DOIUrl":null,"url":null,"abstract":"Targeting cancer using nanomedicine is not a new concept. Earlier focus was on targeted therapy and then concept came of combinational therapy. Along with the use of combinational therapies, Pre-selection screening of the patients using molecular approach is equally important to achieve the maximum benefit to the cancer patients.","PeriodicalId":8322,"journal":{"name":"Archives of Nanomedicine: Open Access Journal","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nanotechnology in Cancer: an Overview on Importance of Patient’s Screening in Nanomedicine Based Combinational Therapies\",\"authors\":\"Subodh Kumar, P. Sarma, R. Singh, D. Reddy, Sukhjinder Singh, Ashutosh Singh, B. Medhi\",\"doi\":\"10.32474/ANOAJ.2018.01.000112\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Targeting cancer using nanomedicine is not a new concept. Earlier focus was on targeted therapy and then concept came of combinational therapy. Along with the use of combinational therapies, Pre-selection screening of the patients using molecular approach is equally important to achieve the maximum benefit to the cancer patients.\",\"PeriodicalId\":8322,\"journal\":{\"name\":\"Archives of Nanomedicine: Open Access Journal\",\"volume\":\"4 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Nanomedicine: Open Access Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32474/ANOAJ.2018.01.000112\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Nanomedicine: Open Access Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32474/ANOAJ.2018.01.000112","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Nanotechnology in Cancer: an Overview on Importance of Patient’s Screening in Nanomedicine Based Combinational Therapies
Targeting cancer using nanomedicine is not a new concept. Earlier focus was on targeted therapy and then concept came of combinational therapy. Along with the use of combinational therapies, Pre-selection screening of the patients using molecular approach is equally important to achieve the maximum benefit to the cancer patients.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
